Manufacturing costs of HPV vaccines for developing countries
详细信息 查看全文
- 作者：Chaevia Clendinena ; csclendi@gmail.com" class="auth_mail" title="E-mail the corresponding author ; Yapei Zhangb ; yapei.zhang@yale.edu" class="auth_mail" title="E-mail the corresponding author ; Rebecca N. Warburtonc ; rnwarbur@uvic.ca" class="auth_mail" title="E-mail the corresponding author ; Donald W. Lightd ; lightdo@rowan.edu" class="auth_mail" title="E-mail the corresponding author
- 关键词：Vaccine ; Manufacturing cost ; Gavi ; Human papillomavirus ; Affordability ; Access
- 刊名：Vaccine
- 出版年：2016
- 出版时间：21 November 2016
- 年：2016
- 卷：34
- 期：48
- 页码：5984-5989
- 全文大小：655 K
文摘
- •
This is one of the few original investigations of vaccine manufacturing and costs.
- •
Manufacturing costs of Gardasil-4 are much lower than the “no profits” price to Gavi.
- •
Lower sales make per-unit costs of Cervarix much higher than Gardasil.
- •
This study may have relevance to the costs and fair pricing of other vaccines.